Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug reimbursement
Payers
CMS unveils details on coverage for new Alzheimer's meds
The coverage plan will be likely put to the test with a potential approval for Biogen and Eisai's Leqembi slated for this summer.
Heather Landi
Jun 23, 2023 11:00am
Hospitals' 340B participation linked to reduced biosimilar use
May 2, 2023 1:13pm
Political headwinds grow against CMMI drug price model
Mar 13, 2023 8:30am
CMMI releases three new models to curb drug costs
Feb 14, 2023 4:34pm
OIG: CMS needs to help drugmakers calculate Medicare prices
Jan 3, 2023 5:55pm
Payers cheer CMS decision on Aduhelm coverage
Apr 11, 2022 12:00pm
